Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Veterinary Pain Management Market Future Outlook, Trends & Forecast Analysis (2024-2032)
Veterinary Pain Management Market Size Was Valued at USD 2.10 Billion in 2023, and is Projected to Reach USD 3.69 Billion by 2032, Growing at a CAGR of 6.47 % From 2024-2032. The Veterinary Pain Management Market refers to the products including treatments, medicines, and instruments intended for the management of pain in animals as a result of osteoarthritis, surgery, cancer or an injury.
IMR Group
Description
Veterinary Pain Management Market Synopsis:
Veterinary Pain Management Market Size Was Valued at USD 2.10 Billion in 2023, and is Projected to Reach USD 3.69 Billion by 2032, Growing at a CAGR of 6.47 % From 2024-2032.
The Veterinary Pain Management Market refers to the products including treatments, medicines, and instruments intended for the management of pain in animals as a result of osteoarthritis, surgery, cancer or an injury. Medicines, chemistries various other treatments, analgesics, and splendid varieties for the treatment of pets, livestock, and other animals are included in this market.
Veterinary pain management markets have been expanding steadily across the globe because instances of arthritis and cancer in companion and livestock animals continue to rise. This market has been innovated by enhanced awareness amongst the owners of animals coupled with appropriate access to improved physical animal health care services. In addition, with the recent shift in customers’ perception of their pets known as the pet’s humanization, there was the need to come up with a useful product in the management of pain.
Another advancement has also been achieved in the knowledge of veterinary drugs and emergence of features that create minimal invasive techniques that improve treatment outcome. With a rising trend of livestock keeping plus enhanced welfare standards imposed on the animals, the usage of analgesics in farm animals has also been on the rise. In sum all these factors indicate a favorable environment for the expansion of veterinary pain management market.
Veterinary Pain Management Market Trend Analysis:
Increased Focus on Companion Animal Pain Management
The growing global population of pets is affecting the pattern of the veterinary pain management market. Pets in the present generation are not only regarded as mere animals but rather as members of the family this has led to many pets to make health care and spending unit visits. Current owners would have the potential of making substantial payments on matters that are long-term treatments such as adoption of new healthy foods and therapies such as laser and acupuncture for treatment of pain. However, extending-release pain control products and regenerative medicine also depict the concern towards outcomes of pain control aspects for pets.
Advancements in Pain Management Technologies
New technologies for pain management are the biggest opportunity that has presented itself to players in the market. Non-pharmacological related treatments such as TENS and pulse therapies are turning to a much more radical treatment solution than conventional painkiller drugs. Increasing applications of biologics and gene therapies in the present and future are becoming apparent as possessing potential for the treatment of chronic pain and therefore opening up the market.
Veterinary Pain Management Market Segment Analysis:
Veterinary Pain Management Market is Segmented on the basis of product, application, end user, and Region.
By Product, the Drugs segment is expected to dominate the market during the forecast period
The veterinary pain management market by drugs will have a higher market share during the forecast period because NSAIDs, opioids, and anesthetics are widely used. They are fast-acting and in addition, provide sustainable effects for which they remain the best for a vet. Multiply applications, a rising number of approvals for new analgesic molecules and availability of these medications bolster this category further.
By Application, Osteoarthritis, and Joint Pain segment is expected to hold the largest share
Joint disorders, including osteoarthritis/failure and joint pain, which are the most common chronic diseases in elderly pets, are therefore, by far the largest segment of the veterinary pain control market. Most of these dogs are affected by joint-related complaints which other dogs need to receive painful injections for comfort. With reference to the present road-map plan and direction, this segment is being sustained by regenerative treatments and nutraceuticals availability.
Veterinary Pain Management Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America due to better infrastructure for veterinary treatment and more awareness in the region than in others. For example, the how has higher percentage of pet owners and Modern and improved veterinary surgeries offering pain control services. Most of the leading pharmaceutical companies are located in North America, in addition to ongoing efforts to research new forms of additional therapies to create an even greater market for themselves.
Also, a greater number of cases of diseases such as osteoarthritis and cancer among pets are the reason that is prompting companion animal clients to seek pain management solutions. This region has high pet insurance and this gives the owners the confidence to undertake expensive treatments for their pets without interference. Besides, an increased concern of governments to the question of animal suffering and special efforts of the veterinarian associations to draw the high level of attention to the question of painful sensations resulted in a solid domination of this market in North America.
Active Key Players in the Veterinary Pain Management Market:
Boehringer Ingelheim (Germany)
Ceva Santé Animale (France)
Chanelle Pharma (Ireland)
Dechra Pharmaceuticals (United Kingdom)
Elanco Animal Health (United States)
Henry Schein, Inc. (United States)
Heska Corporation (United States)
IDEXX Laboratories (United States)
Merck Animal Health (United States)
Norbrook Laboratories (United Kingdom)
Orion Corporation (Finland)
Vetoquinol S.A. (France)
Virbac S.A. (France)
Zoetis Inc. (United States)
Zomedica Corp. (Canada)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Veterinary Pain Management Market by Drug Class
4.1 Veterinary Pain Management Market Snapshot and Growth Engine
4.2 Veterinary Pain Management Market Overview
4.3 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other: Geographic Segmentation Analysis
Chapter 5: Veterinary Pain Management Market by Viral Type
5.1 Veterinary Pain Management Market Snapshot and Growth Engine
5.2 Veterinary Pain Management Market Overview
5.3 Adenovirus Enterovirus Others
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Adenovirus Enterovirus Others: Geographic Segmentation Analysis
Chapter 6: Veterinary Pain Management Market by Distribution Channel
6.1 Veterinary Pain Management Market Snapshot and Growth Engine
6.2 Veterinary Pain Management Market Overview
6.3 Hospital Pharmacies Retail Pharmacies Online Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacies Retail Pharmacies Online Pharmacies: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Veterinary Pain Management Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 BOEHRINGER INGELHEIM (GERMANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 CEVA SANTÉ ANIMALE (FRANCE)
7.4 CHANELLE PHARMA (IRELAND)
7.5 DECHRA PHARMACEUTICALS (UNITED KINGDOM)
7.6 ELANCO ANIMAL HEALTH (UNITED STATES)
7.7 HENRY SCHEIN INC. (UNITED STATES)
7.8 HESKA CORPORATION (UNITED STATES)
7.9 IDEXX LABORATORIES (UNITED STATES)
7.10 MERCK ANIMAL HEALTH (UNITED STATES)
7.11 NORBROOK LABORATORIES (UNITED KINGDOM)
7.12 ORION CORPORATION (FINLAND)
7.13 VETOQUINOL S.A. (FRANCE)
7.14 VIRBAC S.A. (FRANCE)
7.15 ZOETIS INC. (UNITED STATES)
7.16 ZOMEDICA CORP. (CANADA)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Veterinary Pain Management Market By Region
8.1 Overview
8.2. North America Veterinary Pain Management Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Drug Class
8.2.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.2.5 Historic and Forecasted Market Size By Viral Type
8.2.5.1 Adenovirus Enterovirus Others
8.2.6 Historic and Forecasted Market Size By Distribution Channel
8.2.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Veterinary Pain Management Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Drug Class
8.3.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.3.5 Historic and Forecasted Market Size By Viral Type
8.3.5.1 Adenovirus Enterovirus Others
8.3.6 Historic and Forecasted Market Size By Distribution Channel
8.3.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Veterinary Pain Management Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Drug Class
8.4.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.4.5 Historic and Forecasted Market Size By Viral Type
8.4.5.1 Adenovirus Enterovirus Others
8.4.6 Historic and Forecasted Market Size By Distribution Channel
8.4.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Veterinary Pain Management Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Drug Class
8.5.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.5.5 Historic and Forecasted Market Size By Viral Type
8.5.5.1 Adenovirus Enterovirus Others
8.5.6 Historic and Forecasted Market Size By Distribution Channel
8.5.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Veterinary Pain Management Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Drug Class
8.6.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.6.5 Historic and Forecasted Market Size By Viral Type
8.6.5.1 Adenovirus Enterovirus Others
8.6.6 Historic and Forecasted Market Size By Distribution Channel
8.6.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Veterinary Pain Management Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Drug Class
8.7.4.1 Antibiotics Artificial tears Decongestants Anti-histamines NSAIDS Anti-Viral drugs Other
8.7.5 Historic and Forecasted Market Size By Viral Type
8.7.5.1 Adenovirus Enterovirus Others
8.7.6 Historic and Forecasted Market Size By Distribution Channel
8.7.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Veterinary Pain Management Market research report?
A1: The forecast period in the Veterinary Pain Management Market research report is 2024-2032.
Q2: Who are the key players in the Veterinary Pain Management Market?
A2: Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, and Other Active Players.
Q3: What are the segments of the Veterinary Pain Management Market?
A3: The Veterinary Pain Management Market is segmented into Product, Application, End User, and region. By Product, the market is categorized into drug devices. By Application, the market is categorized into Osteoarthritis Joint Pain Postoperative Pain Cancer Others. By End User, the market is categorized into Hospitals Clinics, and Retail Outlet Others. North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Veterinary Pain Management Market?
A4: The Veterinary Pain Management Market refers to the products including treatments, medicines, and instruments intended for the management of pain in animals as a result of osteoarthritis, surgery, cancer, or an injury. Medicines, chemistries, and various other treatments, analgesics, and splendid varieties for the treatment of pets, livestock, and other animals are included in this market.
Q5: How big is the Veterinary Pain Management Market?
A5: Veterinary Pain Management Market Size Was Valued at USD 2.10 Billion in 2023, and is Projected to Reach USD 3.69 Billion by 2032, Growing at a CAGR of 6.47 % From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
